DisperSol
Business Services · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
111 Cooperative Way Bldg 2-200, Georgeto...Phone Number
(512) 686-4740Website
www.dispersoltech.comRevenue
$8.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About DisperSol
DisperSol is a clinical-stage drug development company focused on developing new treatments for patients utilizing its proprietary KinetiSol® technology platform. KinetiSol has proven capable of creating novel therapeutics from poorly bioavailable drugs to deliver unique clinical benefits to patients. The platform enables a drug development path forward to patients when other options fail to make a difference. DisperSol's active programs include, DST-0509 about to enter Phase 3 for iron overload disorder and DST-2970 in Phase 2 for refractory metastatic prostate cancer. Additional earlier-stage programs include DST-5407 for non-squamous non-small cell lung cancer.Explore more
DisperSol Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is DisperSol your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when DisperSol launches new products
Congratulate Masked Content for being promoted to Masked Content at DisperSol
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if DisperSol had a recent Job posting/layoffs
Funding: Get notified immidiatlly once DisperSol has new funding data
DisperSol, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on DisperSol recently announced quarterly report
Check out if DisperSol is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if DisperSol has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at DisperSol
Find more new buyers
Compare Similar Companies to DisperSol
Compare insights from companies similar to DisperSol, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
DisperSol is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
DisperSol is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about DisperSol.
DisperSol financials insights
Gather financial insights about DisperSol, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Unspecified
$641K
2013
Debt
$611K
2014
Private Equity
$3M
2015
Private Equity
$10M
2016
Private Equity
$12M
2018
Private Equity
$16M
Unspecified
$27M
2020
Debt
$1M
DisperSol Tech Stack
A closer look at the technologies used by DisperSol
Most Recent Scoops
Project
A front-line source in Facilities Management has indicated that the organization is planning to release a request for proposal (RFP) for initiatives related to building management software within the next six to nine months. Jonathon DenBeste currently serves as Manager, Facilities & Asset Compliance At Dispersol Technologies Llc.
Compliance, Enterprise Software, Software, Facilities Management
Project
A front-line source in Facilities Management has indicated that the organization is planning to release a request for proposal (RFP) for initiatives related to maintenance management within the next six to nine months. Jonathon Den Beste currently serves as Manager, Facilities & Asset Compliance At Dispersol Technologies Llc.
Asset Management, Compliance, Facilities Management, Logistics / Supply Chain
Project
A front-line source in Facilities Management has indicated that the organization is planning to begin initiatives related to physical security within six to nine months. DisperSol is currently evaluating vendors to support these efforts. Jonathon Den Beste currently serves as Manager, Facilities & Asset Compliance At Dispersol Technologies Llc.
Compliance, Security, Facilities Management
Project
A front-line source in Facilities Management has indicated that the organization is planning to begin initiatives related to computerized maintenance management system (cmms) within six to nine months. DisperSol is currently evaluating vendors to support these efforts. Jonathon Den Beste currently serves as Manager, Facilities & Asset Compliance At Dispersol Technologies Llc.
Database, Compliance, Operating Systems, Software, Facilities Management
Project
Compliance, Real Estate, Facilities Management
DisperSol News & Media
DisperSol Technologies Announces Collaboration with Ajax Therapeutics to Develop Enhanced KinetiSol Drug Formulations
GEORGETOWN, Texas--(BUSINESS WIRE)--DisperSol Technologies LLC announced today that it is has entered into a research collaboration with Ajax Therapeutics, Inc. to apply its KinetiSol technology to enhance the bioavailability of an Ajax drug candidate in development for the treatment of hematologic malignancies. “Ajax is taking an innovative approach to developing a pipeline of selectively targeted small molecules and we look forward to applying our proprietary KinetiSol technology to help enhaDisperSol Technologies Promotes Chris Brough to Chief Technology Officer - Opera News
DisperSol Technologies LLC announced today that it is promoting Chris Brough from Vice President Technology to Chief Technology Officer effective immediately. “Chris Brough has been an integral figure in DisperSol since itsDisperSol and Catalent Collaborate to Establish KinetiSol® Technology Manufacturing Hub for DisperSol Pharmaceutical Pipeline
GEORGETOWN, Texas & SOMERSET, N.J.--(BUSINESS WIRE)--DisperSol and Catalent Collaborate to Establish KinetiSol Technology Manufacturing Hub for DisperSol Pharmaceutical PipelineDisperSol Technologies Promotes Dave Miller to Chief Scientific Officer
GEORGETOWN, Texas--(BUSINESS WIRE)--DisperSol Technologies, a pharmaceutical industry leader in bioavailability enhancement, is promoting Dave A. Miller to Chief Scientific Officer.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding DisperSol
Sign Up For FreeTo access detailed company insights
DisperSol is a clinical-stage drug development company focused on developing new treatments for patients utilizing its proprietary KinetiSol® technology platform. KinetiSol has proven capable of creating novel therapeutics from poorly bioavailable drugs to deliver unique clinical benefits to patients. The platform enables a drug development path fo... Read More
